KYNU and psoriasis: Induced psoriasis-like symptoms in mice were reduced after the application of KYNU inhibitors, and the knockdown of KYNU significantly inhibited the production of inflammatory cytokines in keratinocyte cell lines; altogether, these observations suggest that KYNU represents a likely therapeutic target in psoriasis89.